Stem Cell Therapy Market Report 2026

Stem Cell Therapy Market Overview

• Stem Cell Therapy market size has reached to $9.26 billion in 2025 • Expected to grow to $16.12 billion in 2030 at a compound annual growth rate (CAGR) of 11.3% • Growth Driver: Growing Development Of Personalized Medicine To Drive Market Growth • Market Trend: Advancements In Automated Platforms For Cell Therapy Manufacturing • North America was the largest region in 2025 and Middle East is the fastest growing region.

What Is Covered Under Stem Cell Therapy Market?

Stem cell therapy refers to a form of regenerative medicine that uses stem cells or their byproducts to stimulate the body's natural repair process in damaged, malfunctioning, or wounded tissue. It is the next step in the transplantation of organs, replacing donor organs which are scarce with cells. The main types of stem cell therapy are allogeneic stem cell therapy and autologous stem cell therapy. Allogeneic stem cell transplantation involves transferring stem cells from a healthy person (the donor) to the patient's body after high-intensity chemotherapy or radiation. The various sources of the cells include adult stem cells, induced pluripotent stem cells, and embryonic stem cells that are used for the treatment of musculoskeletal disorders, wounds and injuries, cancer, autoimmune disorders, and others. The therapies are used by hospitals and clinics.

What Is The Stem Cell Therapy Market Growth Forecast?

The stem cell therapy market size is expected to see rapid growth in the next few years. It will grow to $16.12 billion in 2030 at a compound annual growth rate (CAGR) of 11.3%. The growth in the forecast period can be attributed to expanding therapeutic applications beyond hematology, improving clinical outcomes through combination therapies, rising investment from biotechnology firms, increasing acceptance by regulatory authorities, growing demand for personalized medicine. Major trends in the forecast period include expansion of cell-based regenerative therapies, rising adoption of autologous stem cell procedures, increasing clinical trials for multisystem disorders, advancements in stem cell banking infrastructure, growing integration of stem cell therapy in oncology.

Global Stem Cell Therapy Market Segmentation

1) By Type: Allogeneic Stem Cell Therapy, Autologous Stem Cell Therapy 2) By Cell Source: Adult Stem Cells, Induced Pluripotent Stem Cells, Embryonic Stem Cells 3) By Application: Musculoskeletal Disorders and Wounds & Injuries, Cancer, Autoimmune Disorders, Others 4) By End-Users: Hospitals And Clinics, Research Centers, Others

What Is The Driver Of The Stem Cell Therapy Market?

The increasing development of personalized medicine is expected to propel the growth of stem cell therapy market going forward. Personalized medicine, also known as precision medicine, is an approach to medical treatment and healthcare that takes into account individual variability in genes, environment, and lifestyle when developing treatment plans for patients. Personalized medicine tailors stem cell treatments to individual patients based on their unique genetic and medical profiles, enhancing treatment effectiveness, reducing adverse effects, and prioritizing patient well-being. This patient-centred approach, coupled with precise patient selection, more effective clinical trials, and market expansion, is expected to make stem cell therapies more appealing and fuel market growth. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, in 2023, FDA approved 16 new personalized treatments for rare disease patients, up from six in 2022. The newly approved personalized treatments for 2023 also include seven cancer drugs and three for other diseases and conditions. Therefore, the increasing development of personalized medicine is driving the growth of stem cell therapy industry.

Key Players In The Global Stem Cell Therapy Market

Major companies operating in the stem cell therapy market are Fujifilm Holding Corporation, Thermo Fisher Scientific Inc., Takara Bio Inc., MEDIPOST Co. Ltd., Astellas Pharma Inc., Catalent Inc., Pharmicell Co. Ltd., JCR Pharmaceuticals Co. Ltd., Stemedica Cell Technologies Inc., Pluristem Technologies Ltd, Becton Dickinson Private Limited, Stem Cell Technologies India Pvt. Ltd, Cordlife India Pvt. Ltd, Lifecell International Pvt. Ltd, Stemcyte India Therapeutics Private Limited, Stempeutics Research Private Limited, Anterogen Co. Ltd, Tonghua Dongbao Pharmaceutical Co, China Biologic Products Holdings Inc, Cellerix, Cellgenix, NSgene, Tigenix, Renuron Group, Smart Cells, Genenta Science, Amsterdam Molecular Therapeutics (AMT), Ark Therapeutics, Arthrogen Bv, Diamyd Medical Ab, Oxford Biomedica, Transgene, Oncoarendi Therapeutics, Celon Pharma, Osiris Therapeutics, Capricortherapeutics, Cellular Dynamics, Discgenics, Takeda Pharmaceuticals, Kolon Tissue Gene, Athersys, Cyro-Cell International, Geron Corporation, Mesoblast Ltd, Astrom Biosciences Inc, Invitrogen, Cytori Therapeutics Inc, Nuvasive Inc, Aldagen Inc, Caladrius Biosciences Inc, Biogen Sa, Gamida Cell Ltd, Hisun Pharma, Novartis

Global Stem Cell Therapy Market Trends and Insights

Major companies operating in the stem cell therapy market are focusing on developing advanced automated manufacturing technologies such as end-to-end microfluidic-based cell processing platforms to improve scalability, consistency, and efficiency in cell therapy production. End-to-end microfluidic-based cell processing platforms are integrated automated systems that use microfluidic technology to perform all key steps of cell therapy manufacturing within a single closed, precise, and scalable unit. For instance, in March 2025, Limula SA, a Switzerland-based cell therapy technology company, launched LimONE, designed to streamline the production of autologous and allogeneic cell therapies. LimONE combines automated cell enrichment, bioprocessing, and final product formulation within one modular system, enabling standardized, scalable, and cost-efficient cell therapy manufacturing. By minimizing process variability and enabling continuous, closed-system production, LimONE enhances manufacturing reliability and supports broader clinical and commercial adoption of stem cell and other cell-based therapies.

What Are Latest Mergers And Acquisitions In The Stem Cell Therapy Market?

In April 2024, Century Therapeutics Inc., a US-based biotechnology company, acquired Clade Therapeutics Inc. for an undisclosed amount. This acquisition is aimed at strengthening Century Therapeutics’ pipeline by integrating Clade’s advanced stem cell engineering technologies, accelerating the development of next-generation allogeneic therapies, and expanding its capabilities across immuno-oncology applications. Clade Therapeutics Inc. is a US-based biotechnology company focused on developing engineered stem cell–derived therapeutics.

Regional Insights

North America was the largest region in the stem cell therapy market in 2025. The Middle East is expected to be the fastest-growing region in the global stem cell therapy market during the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Stem Cell Therapy Market?

The stem cell therapy market includes revenues earned by entities by hematopoietic stem cells, skin stem cells, neural stem cells, and mesenchymal stem cells. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Stem Cell Therapy Market Report 2026?

The stem cell therapy market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the stem cell therapy industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.